Program for all days

• Welcome and ISN Presidential Address
  MarcelloTonelli Speaker Canada
• Jean Hamburger Award Presentation
• Welcome Speech by JSN President
  MasaomiNangaku Speaker Japan
• Welcome Speech by APSN President
  XueqingYU Speaker China
• Welcome Speech by SPWG Chair
  Sydney Tang Speaker Hong Kong, China
• Welcome Speech by the President of Japanese Medical Science Federation and Japanese Association of Medical Science
  TakashiKadowaki Speaker Japan
• Dynamics of the Function and Regulation of the Endoplasmic Reticulum
  KazutoshiMori Speaker Japan
• ISN Film Event Winner Presentation

• REMODEL Trial Overview: Framework and Key Outcomes
  PetterBjornstad Speaker United States
• Semaglutide Improves Kidney Outcomes Regardless Of SGLT2i Use In People With Chronic Kidney Disease And Type 2 Diabetes: Post-hoc Analysis The Remodel Trial
  DavidCherney Speaker Canada
• Aldosterone Blockade for Health Improvement Evaluation in End-stage Renal Disease Trial
  (ACHIEVE)
  MichaelWalsh Speaker lastwalsh1975@gmail.comCanada
• B-cell Targeted Therapy for Idiopathic Nephrotic Syndrome: Results of the Phase III Global Multicenter Inshore Trial Evaluating Efficacy and Safety of Obinutuzumab vs Mycophenolate Mofetil
  JulienHogan Speaker France
• Q&A Session

• RESOLVE Trial: Sodium Concentration in Dialysis Populations — a Global Cluster Randomized Study
  MegJardine Speaker meg.jardine@sydney.edu.auAustralia
• Q&A
• Key Aspects of the VOICE Clinical Trial on Anemia in Dialysis Patients
  ShuchiAnand Speaker sanand3@health.ucdavis.eduUnited States
• Q&A
• The Renal Life Cycle: Development, Maturity, and Decline
  HiddoLambers Heerspink Speaker h.j.lambers.heerspink@umcg.nlNetherlands
• Q&A
• Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-proven Primary Glomerular Diseases: Multi-center, Multi-arm and Multi-stage- the Story So Far
  Joint Presentation
  Selvin Sundar RajMani Speaker India

  SuceenaAlexander Speaker suceena@gmail.comIndia
• Q&A
• ASPIRE Trial: Aspirin Use in Dialysis Patients in China
  XueqingYU Speaker China
• Q&A

• Bywaters Award Presentation
• Podocytopathies: Knowns and Unknowns
  PaolaRomagnani Speaker Italy

• Opening & Introduction
  Sydney Tang Speaker Hong Kong, China
• Efficacy and Safety Results of Atrasentan in Patients With IgA Nephropathy on Sodium‚ äìglucose Co-transporter 2 Inhibitors: Phase II, Randomized, Placebo-controlled, Crossover Trial (Assist)
  HiddoLambers Heerspink Speaker h.j.lambers.heerspink@umcg.nlNetherlands
• Q&A
• Efficacy and Safety of a Targeted-release Formulation of Budesonide (HR19042 Capsules) in Patients With Primary IgA Nephropathy: A Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2/3 Trial
  XiaobingYang Speaker China
• Q&A
• Efficacy and Safety of Iptacopan in Patients With IgA Nephropathy (IgAN): Final 24-month Results From the Phase III APPLAUSE-IgAN Study
  VladoPerkovic Speaker Australia
• Q&A
• Closing Remarks

• SUMOylation of Podocin Reverses the Progression of Diabetic Kidney Disease
  PedroGeraldes Speaker Pedro.Geraldes@USherbrooke.caCanada
• SUMOylation Activates β-Catenin and Contributes to Kidney Fibrosis
  ZhengDong Speaker United States

• Effect of a 12-week Intradialytic Cycling Intervention on Hemodialysis-induced Myocardial Stunning: A Multi-centre Randomized Controlled Trial
  ClaraBohm Speaker Canada
• TEACH-PD Cluster Randomized Controlled Trial: Targeted Education ApproaCH to improve Peritoneal Dialysis Outcomes
  JosephineChow Speaker Australia
• Effect of Finerenone on Circulating Biomarkers: A CONFIDENCE Analysis
  MarioBerger Speaker mario.berger@bayer.comGermany
• Effect of Simultaneous Initiation of Finerenone and Empagliflozin on Urinary Albumin-to-creatinine Ratio by Age and Sex in the CONFIDENCE Trial
  RajivAgarwal Speaker United States
• Estimated Glomerular Filtration Rate, Systolic Blood Pressure, and Urinary Albumin-to-creatinine Ratio — Unravelling the Interplay in Combination: Findings From the CONFIDENCE Trial
  RajivAgarwal Speaker United States
• Lowering-Hyperuricemia Treatment on Cardiovascular Outcomes in Peritoneal Dialysis Patients: A Prospective, Multicenter, Double Blind Randomized Controlled Trial
  Naya Huang Speaker huangnaya@163.comChina

• Schrier Award Presentation
• The Potential of Polypills in CKD
  AnthonyRodgers Speaker Australia

• Advances in the Diagnosis and Detection of CKD
  LuxiaZhang Speaker zhanglx@bjmu.edu.cnChina
• Advances in Understanding the Impact of Sex on Kidney Health and Disease
  KateStevens Speaker kate.stevens@glasgow.ac.ukUnited Kingdom
• Advances in CKD Therapeutics in the Context of Complex Disease Interactions
  AndrejSkoberne Speaker andrej.b.skoberne@gmail.comSlovenia
• Q&A

• KDIGO Updates on Management of CKD Anemia
  WolfgangWinkelmayer Speaker wolfgang.winkelmayer@bcm.eduUnited States
• Why CKD Anemia Care Differs Across Regions
  SunitaBavanandan Speaker sbavanandan@gmail.comMalaysia
• Beyond Erythropoiesis-stimulating Agents and Iron: Navigating the Future of Anemia of Chronic Kidney Disease Management
  Kai-UweEckardt Speaker kai-uwe.eckardt@charite.deGermany
• Q&A

• Genetic Pretesting — Is More Always Better?
  RoserTorra Speaker rtorra@fundacio-puigvert.esSpain
• The Test: Nephro-genomic Board Simulation: Variant Scientist X Genetic Nephrologist
  DanielGale Speaker d.gale@ucl.ac.ukUnited Kingdom
• Risk Alleles and Low-penetrance Variants in Nephrology: Gaps in Evidence
  JanewitWongboonsin Speaker Thailand
• The Patient Voice
  SusieGear Speaker susiegear@alportuk.orgUnited Kingdom
• Q&A

• The ISN Role in Humanitarian Kidney Care
  AliAbu-Alfa Speaker abualfa@aub.edu.lbLebanon
• Disaster Preparedness in Kidney Care: Pitfalls and Solutions
  SerhanTuglular Speaker serhantuglular@yahoo.comTurkey
• Earthquake Disaster: Lessons Learnt from Japan
  KeiFukami Speaker Japan
• Resilient Kidney Care: Adaptation and Recovery After a Disaster
  SabineKaram Speaker sabinejkaram@gmail.comUnited States
• Q&A

• Creating Paradigm Shifts in Medical Diagnostics Using Liquid Biopsy
  Yuk Ming DennisLO Speaker Hong Kong, China
• Congress Closing